Enjoy complimentary customisation on priority with our Enterprise License!
The anticoccidial drugs market size is forecast to increase by USD 85.2 million at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The increasing prevalence of disease outbreaks in livestock populations, particularly coccidial diseases, is driving demand for effective preventative measures. Coccidiosis is a common parasitic disease that affects poultry and livestock, leading to significant economic losses through reduced productivity and increased mortality rates. Moreover, rising awareness among farmers and livestock producers about the importance of disease prevention and the benefits of using feed additives to mitigate coccidiosis is further fueling market growth. Additionally, the increasing dependency on livestock products as a source of protein for the growing global population is creating a strong demand for healthy and disease-free livestock, further boosting the market for coccidiosis feed additives.
For More Highlights About this Report, Request Free Sample
The Market refers to the segment of the animal health industry that deals with the production and distribution of drugs used to prevent and treat coccidiosis in animals. Coccidiosis is a common intestinal disease caused by parasitic organisms of the genus Eimeria, affecting various animal livestock animals and companion animals. The market includes ionophores, antibiotics, sulphonamides, and chemical derivatives, which function as either coccidiostatic or coccidiocidal agents. Ionophores, such as monensin and lasalocid, are widely used in cattle and poultry production. Antibiotics, like sulphonamides, are also used in the treatment of coccidiosis in animals. Creative Diagnostics is one of the key players in the Anticoccidial Market, offering a range of diagnostic services for zootonic diseases. The increasing meat-eating population and demand for poultry and cattle products have fueled the growth of the Anticoccidial Market. Veterinary hospitals, livestock farms, and pet owners are the primary consumers of these drugs. The market is also driven by the growing awareness of animal and veterinary health, as well as the availability of advanced anticoccidial drugs. The use of anticoccidial drugs is essential in preventing the spread of coccidiosis through soil, clothing, shovels, pails, and other means. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Growing demand for feed additives owing to rising disease outbreaks in livestock is notably driving market growth. Anticoccidial drugs play a crucial role in preventing coccidiosis, a disease that affects various livestock populations, including poultry, cattle, swine, and pet animals.
Moreover, Coccidiosis is caused by the ingestion of sporulated oocysts and can lead to nutrient deficiencies, reduced growth rates, and even increased mortality, depending on the species. This disease poses a significant challenge to the livestock industry, disrupting meat production and trade, and negatively impacting the sales of animal feed additives. Thus, such factors are driving the growth of the market during the forecast period.
Advances in biotechnology is the key trend in the market. The Market is witnessing significant growth due to the increasing population of livestock, including poultry, cattle, swine, and pet animals. The demand for animal protein food is surging, leading meat producers to prioritize the health of their livestock. Anticoccidial drugs play a crucial role in preventing coccidiosis, a parasitic disease caused by Eimeria species.
Moreover, advanced anticoccidial drugs are being developed through genomic analysis of these parasites, enabling the identification of species-specific protein targets. This may lead to the launch of new anticoccidial drugs and feed additives, such as the recent introduction of two new veterinary products by Elanco Animal Health Inc. in Sri Lanka. Thus, such trends will shape the growth of the market during the forecast period.
Stringent government regulations is the major challenge that affects the growth of the market. Anticoccidial drugs are essential in the livestock industry for the prevention and treatment of coccidiosis, a parasitic disease that affects various animal populations, including poultry, cattle, swine, and pet animals. These drugs come in different forms, such as advanced synthetic drugs like robenidine, decoquinate, halofuginone, nicarbazin, and diclazuril, and herbal medicines.
Moreover, government regulations impose restrictions on the use of veterinary drugs or feed additives, including anticoccidials. In the European Union, anticoccidial drugs are licensed as zootechnical feed additives under regulation 1831/2003/EC for species where coccidiosis is systematic, while in other species, they are registered as veterinary medicines. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bayer AG: The company offers anticoccidial that includes Polyether antibiotics, Ionophores, Monovalent ionophores, and Monovalent glycosidic ionophores.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The ionophore anticoccidial segment is estimated to witness significant growth during the forecast period. The Anticoccidial Market encompasses ionophores, antibiotics such as sulphonamides, and chemical derivatives used to prevent and treat coccidiosis in animal livestock and companion animals. Coccidiostats inhibit the multiplication of parasitic organisms like Eimeria tenella and other Eimeria species, while coccidiocidals eliminate the parasites.
Get a glance at the market share of various regions Download the PDF Sample
The ionophore anticoccidial segment was the largest segment and valued at USD 169.80 million in 2018. These diseases, which cause diarrhea and dehydration, can significantly impact breeding and productivity in animals. Creative Diagnostics offers a range of antimicrobial anticoccidial drugs for veterinary healthcare. Zoonotic diseases, such as coccidiosis, can spread from animals to humans, making animal health a critical concern for the meat-eating population. Antibiotic-free meat and poultry products are increasingly popular, necessitating effective alternatives to antibiotics for livestock health management. Hence, such factors are fuelling the growth of this segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 52% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Anticoccidial Market encompasses ionophores, antibiotics such as sulphonamides, and chemical derivatives used to prevent and treat coccidiosis in animal livestock and companion animals. Coccidiostatic and coccidiocidal drugs are essential in controlling parasitic diseases like coccidiosis, which is caused by Eimeria species, including E. tenella. This intestinal disease leads to diarrhea and dehydration, affecting breeding and productivity in cattle, poultry, and other animals. Creative Diagnostics offers a range of antimicrobial anticoccidial drugs for veterinary healthcare. Hence, such factors are driving the market in North America during the forecast period.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments
You may also interested in below market reports:
The Market refers to the segment of the animal health industry that deals with the production and sale of anticoccidial drugs. These drugs are used to prevent and treat coccidiosis, a parasitic disease caused by Eimeria species, in animals such as cattle, poultry, and companion animals. Anticoccidial drugs can be categorized into ionophores, antibiotics, and chemical derivatives, with coccidiostatic and coccidiocidal being the two main types. Ionophores, such as monensin and lasalocid, are ionophore anticoccidials, while sulphonamides and antibiotic-free antimicrobial drugs are antibiotic anticoccidials. The market landscape depends on the Oocyst, Vaccines, Swine population, Pet animals population, Puppies, Kittens, Environmental contamination, and Veterinary population. Coccidiosis is a common zootonic disease that affects various animal livestock animals and companion animals, leading to diarrhea, dehydration, and intestinal disease. The disease is caused by the parasitic organism Eimeria, which is spread through oocysts in the soil, water, and on clothing, shovels, and pails. The Anticoccidial Market is driven by the increasing demand for animal health and veterinary healthcare, veterinary health awareness, and the growing meat-eating population's demand for cattle products and poultry products. Key players in the market include Creative Diagnostics, Animals, and various other animal drug manufacturers. Government involvement in livestock health management also plays a significant role in market growth.
Market Scope |
|
Report Coverage |
Details |
Page number |
139 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market growth 2024-2028 |
USD 85.2 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.24 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 52% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., HIPRA S A, Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac SA, and Zoetis Inc. |
Market dynamics |
Parent market analysis, market report, market forecast , Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.